United States · FDA National Drug Code directory
Haloperidol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-0581_0f6d8b89-8c33-4459-84af-e588eb27587c
- Product NDC
- 0121-0581
- Form
- SOLUTION
- Composition / generic term
- Haloperidol
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091110
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 120 mL in 1 BOTTLE (0121-0581-04) · 0121-0581-04
- 10 TRAY in 1 CASE (0121-0581-05) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE · 0121-0581-05
- 15 mL in 1 BOTTLE (0121-0581-15) · 0121-0581-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →